Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.57045
-0.0131 (-2.24%)
At close: Jul 8, 2026, 4:00 PM EDT
0.5684
-0.0020 (-0.36%)
After-hours: Jul 8, 2026, 7:49 PM EDT
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $15.66 million as of July 8, 2026. Its market cap has increased by 47.74% in one year.
Market Cap
15.66M
Enterprise Value
11.52M
1-Year Change
47.74%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $15.66M, a decrease of -48.99%. That is a compound annual growth rate of -7.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 15.30M | -4.97% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 17.55M |
| GT Biopharma | 17.49M |
| Quince Therapeutics | 17.20M |
| Chemomab Therapeutics | 16.80M |
| Moolec Science | 16.57M |
| Werewolf Therapeutics | 15.89M |
| Tempest Therapeutics | 15.84M |
| BioVie | 15.84M |